nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—Estramustine—prostate cancer	0.133	0.2	CbGbCtD
Mannitol—ABCB1—Cabazitaxel—prostate cancer	0.0876	0.132	CbGbCtD
Mannitol—ABCB1—Estrone—prostate cancer	0.0857	0.129	CbGbCtD
Mannitol—ABCB1—Ethinyl Estradiol—prostate cancer	0.0763	0.115	CbGbCtD
Mannitol—ABCB1—Conjugated Estrogens—prostate cancer	0.056	0.0843	CbGbCtD
Mannitol—ABCB1—Mitoxantrone—prostate cancer	0.0509	0.0767	CbGbCtD
Mannitol—ABCB1—Estradiol—prostate cancer	0.0492	0.074	CbGbCtD
Mannitol—ABCB1—Prednisone—prostate cancer	0.0423	0.0637	CbGbCtD
Mannitol—ABCB1—Etoposide—prostate cancer	0.0321	0.0483	CbGbCtD
Mannitol—ABCB1—Docetaxel—prostate cancer	0.0294	0.0442	CbGbCtD
Mannitol—ABCB1—Doxorubicin—prostate cancer	0.0219	0.033	CbGbCtD
Mannitol—N-Acetyl-D-glucosamine—NAGK—prostate cancer	0.00568	0.333	CrCbGaD
Mannitol—N-Acetyl-D-glucosamine—NAGLU—prostate cancer	0.00568	0.333	CrCbGaD
Mannitol—N-Acetyl-D-glucosamine—B4GALT4—prostate cancer	0.00568	0.333	CrCbGaD
Mannitol—ABCB1—Abacavir transmembrane transport—SLC22A3—prostate cancer	0.000604	0.0907	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transmembrane transport—SLC22A1—prostate cancer	0.000492	0.0739	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transport and metabolism—SLC22A3—prostate cancer	0.000347	0.0521	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transport and metabolism—SLC22A1—prostate cancer	0.000283	0.0425	CbGpPWpGaD
Mannitol—ABCB1—Codeine and Morphine Metabolism—CYP3A4—prostate cancer	0.000232	0.0349	CbGpPWpGaD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—prostate cancer	0.00018	0.0271	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000148	0.0223	CbGpPWpGaD
Mannitol—Abdominal pain upper—Doxorubicin—prostate cancer	0.000139	0.000446	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—prostate cancer	0.000138	0.000444	CcSEcCtD
Mannitol—Nausea—Conjugated Estrogens—prostate cancer	0.000138	0.000443	CcSEcCtD
Mannitol—Urticaria—Mitoxantrone—prostate cancer	0.000138	0.000441	CcSEcCtD
Mannitol—Back pain—Capecitabine—prostate cancer	0.000137	0.000441	CcSEcCtD
Mannitol—Hypersensitivity—Estradiol—prostate cancer	0.000137	0.000439	CcSEcCtD
Mannitol—Body temperature increased—Mitoxantrone—prostate cancer	0.000137	0.000439	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—prostate cancer	0.000137	0.000438	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—prostate cancer	0.000136	0.000436	CcSEcCtD
Mannitol—Hypotension—Etoposide—prostate cancer	0.000135	0.000432	CcSEcCtD
Mannitol—Vision blurred—Capecitabine—prostate cancer	0.000134	0.000429	CcSEcCtD
Mannitol—Asthenia—Estradiol—prostate cancer	0.000133	0.000428	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000132	0.000423	CcSEcCtD
Mannitol—Ill-defined disorder—Capecitabine—prostate cancer	0.000132	0.000423	CcSEcCtD
Mannitol—Pruritus—Estradiol—prostate cancer	0.000132	0.000422	CcSEcCtD
Mannitol—Dyspnoea—Etoposide—prostate cancer	0.000128	0.000412	CcSEcCtD
Mannitol—Malaise—Capecitabine—prostate cancer	0.000128	0.000411	CcSEcCtD
Mannitol—Cough—Docetaxel—prostate cancer	0.000128	0.000411	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—prostate cancer	0.000128	0.000411	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000128	0.0192	CbGpPWpGaD
Mannitol—Vertigo—Capecitabine—prostate cancer	0.000128	0.000409	CcSEcCtD
Mannitol—Hypersensitivity—Mitoxantrone—prostate cancer	0.000128	0.000409	CcSEcCtD
Mannitol—Mental disorder—Prednisone—prostate cancer	0.000127	0.000409	CcSEcCtD
Mannitol—Diarrhoea—Estradiol—prostate cancer	0.000127	0.000408	CcSEcCtD
Mannitol—Convulsion—Docetaxel—prostate cancer	0.000127	0.000408	CcSEcCtD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—prostate cancer	0.000127	0.0191	CbGpPWpGaD
Mannitol—Hypertension—Docetaxel—prostate cancer	0.000127	0.000406	CcSEcCtD
Mannitol—Infestation—Epirubicin—prostate cancer	0.000127	0.000406	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—prostate cancer	0.000127	0.000406	CcSEcCtD
Mannitol—Malnutrition—Prednisone—prostate cancer	0.000127	0.000406	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—prostate cancer	0.000126	0.000405	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.000126	0.019	CbGpPWpGaD
Mannitol—Decreased appetite—Etoposide—prostate cancer	0.000125	0.000402	CcSEcCtD
Mannitol—Arthralgia—Docetaxel—prostate cancer	0.000125	0.000401	CcSEcCtD
Mannitol—Chest pain—Docetaxel—prostate cancer	0.000125	0.000401	CcSEcCtD
Mannitol—Renal failure—Epirubicin—prostate cancer	0.000125	0.000399	CcSEcCtD
Mannitol—Gastrointestinal disorder—Etoposide—prostate cancer	0.000124	0.000399	CcSEcCtD
Mannitol—Asthenia—Mitoxantrone—prostate cancer	0.000124	0.000399	CcSEcCtD
Mannitol—Fatigue—Etoposide—prostate cancer	0.000124	0.000399	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000124	0.000398	CcSEcCtD
Mannitol—Cough—Capecitabine—prostate cancer	0.000124	0.000398	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—prostate cancer	0.000123	0.000396	CcSEcCtD
Mannitol—Pain—Etoposide—prostate cancer	0.000123	0.000395	CcSEcCtD
Mannitol—Dizziness—Estradiol—prostate cancer	0.000123	0.000394	CcSEcCtD
Mannitol—Hypertension—Capecitabine—prostate cancer	0.000123	0.000393	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SERPINB10—prostate cancer	0.000122	0.0184	CbGpPWpGaD
Mannitol—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000122	0.000392	CcSEcCtD
Mannitol—Arthralgia—Capecitabine—prostate cancer	0.000121	0.000388	CcSEcCtD
Mannitol—Chest pain—Capecitabine—prostate cancer	0.000121	0.000388	CcSEcCtD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.00012	0.0181	CbGpPWpGaD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.00012	0.000385	CcSEcCtD
Mannitol—Oedema—Docetaxel—prostate cancer	0.00012	0.000384	CcSEcCtD
Mannitol—Discomfort—Capecitabine—prostate cancer	0.00012	0.000383	CcSEcCtD
Mannitol—Vision blurred—Prednisone—prostate cancer	0.000119	0.000383	CcSEcCtD
Mannitol—Infection—Docetaxel—prostate cancer	0.000119	0.000382	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—BNIP3—prostate cancer	0.000119	0.0179	CbGpPWpGaD
Mannitol—Feeling abnormal—Etoposide—prostate cancer	0.000119	0.000381	CcSEcCtD
Mannitol—Diarrhoea—Mitoxantrone—prostate cancer	0.000119	0.00038	CcSEcCtD
Mannitol—Vomiting—Estradiol—prostate cancer	0.000118	0.000379	CcSEcCtD
Mannitol—Nervous system disorder—Docetaxel—prostate cancer	0.000117	0.000377	CcSEcCtD
Mannitol—Ill-defined disorder—Prednisone—prostate cancer	0.000117	0.000377	CcSEcCtD
Mannitol—Rash—Estradiol—prostate cancer	0.000117	0.000376	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—prostate cancer	0.000117	0.000376	CcSEcCtD
Mannitol—Infestation—Doxorubicin—prostate cancer	0.000117	0.000376	CcSEcCtD
Mannitol—Dermatitis—Estradiol—prostate cancer	0.000117	0.000376	CcSEcCtD
Mannitol—Tachycardia—Docetaxel—prostate cancer	0.000117	0.000375	CcSEcCtD
Mannitol—Headache—Estradiol—prostate cancer	0.000117	0.000374	CcSEcCtD
Mannitol—Skin disorder—Docetaxel—prostate cancer	0.000116	0.000373	CcSEcCtD
Mannitol—Oedema—Capecitabine—prostate cancer	0.000116	0.000372	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—prostate cancer	0.000115	0.00037	CcSEcCtD
Mannitol—Infection—Capecitabine—prostate cancer	0.000115	0.00037	CcSEcCtD
Mannitol—ABCB1—ABC-family proteins mediated transport—ABCG5—prostate cancer	0.000115	0.0172	CbGpPWpGaD
Mannitol—Urticaria—Etoposide—prostate cancer	0.000115	0.000367	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—prostate cancer	0.000114	0.000366	CcSEcCtD
Mannitol—Malaise—Prednisone—prostate cancer	0.000114	0.000366	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—prostate cancer	0.000114	0.000366	CcSEcCtD
Mannitol—Body temperature increased—Etoposide—prostate cancer	0.000114	0.000365	CcSEcCtD
Mannitol—Nervous system disorder—Capecitabine—prostate cancer	0.000114	0.000365	CcSEcCtD
Mannitol—Vertigo—Prednisone—prostate cancer	0.000114	0.000365	CcSEcCtD
Mannitol—Tachycardia—Capecitabine—prostate cancer	0.000113	0.000363	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—prostate cancer	0.000113	0.000362	CcSEcCtD
Mannitol—Skin disorder—Capecitabine—prostate cancer	0.000113	0.000361	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—prostate cancer	0.000112	0.00036	CcSEcCtD
Mannitol—Hypotension—Docetaxel—prostate cancer	0.000112	0.000359	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—prostate cancer	0.000112	0.000358	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—prostate cancer	0.000111	0.000358	CcSEcCtD
Mannitol—Nausea—Estradiol—prostate cancer	0.00011	0.000354	CcSEcCtD
Mannitol—Vomiting—Mitoxantrone—prostate cancer	0.00011	0.000353	CcSEcCtD
Mannitol—Convulsion—Prednisone—prostate cancer	0.00011	0.000352	CcSEcCtD
Mannitol—Hypertension—Prednisone—prostate cancer	0.000109	0.00035	CcSEcCtD
Mannitol—Rash—Mitoxantrone—prostate cancer	0.000109	0.00035	CcSEcCtD
Mannitol—Dermatitis—Mitoxantrone—prostate cancer	0.000109	0.00035	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000109	0.00035	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.000109	0.0163	CbGpPWpGaD
Mannitol—Headache—Mitoxantrone—prostate cancer	0.000109	0.000348	CcSEcCtD
Mannitol—Hypotension—Capecitabine—prostate cancer	0.000108	0.000348	CcSEcCtD
Mannitol—Arthralgia—Prednisone—prostate cancer	0.000108	0.000346	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000107	0.000343	CcSEcCtD
Mannitol—Dyspnoea—Docetaxel—prostate cancer	0.000107	0.000342	CcSEcCtD
Mannitol—Discomfort—Prednisone—prostate cancer	0.000106	0.000341	CcSEcCtD
Mannitol—Hypersensitivity—Etoposide—prostate cancer	0.000106	0.000341	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000106	0.000339	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—prostate cancer	0.000105	0.000338	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—prostate cancer	0.000104	0.000335	CcSEcCtD
Mannitol—Decreased appetite—Docetaxel—prostate cancer	0.000104	0.000334	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—prostate cancer	0.000104	0.000333	CcSEcCtD
Mannitol—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000103	0.000332	CcSEcCtD
Mannitol—Asthenia—Etoposide—prostate cancer	0.000103	0.000332	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—prostate cancer	0.000103	0.000332	CcSEcCtD
Mannitol—Dyspnoea—Capecitabine—prostate cancer	0.000103	0.000332	CcSEcCtD
Mannitol—Oedema—Prednisone—prostate cancer	0.000103	0.000331	CcSEcCtD
Mannitol—Fatigue—Docetaxel—prostate cancer	0.000103	0.000331	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—prostate cancer	0.000103	0.000331	CcSEcCtD
Mannitol—Nausea—Mitoxantrone—prostate cancer	0.000103	0.00033	CcSEcCtD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000103	0.0154	CbGpPWpGaD
Mannitol—Infection—Prednisone—prostate cancer	0.000103	0.000329	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—prostate cancer	0.000102	0.000329	CcSEcCtD
Mannitol—Pain—Docetaxel—prostate cancer	0.000102	0.000329	CcSEcCtD
Mannitol—Chills—Epirubicin—prostate cancer	0.000102	0.000327	CcSEcCtD
Mannitol—Pruritus—Etoposide—prostate cancer	0.000102	0.000327	CcSEcCtD
Mannitol—Nervous system disorder—Prednisone—prostate cancer	0.000101	0.000325	CcSEcCtD
Mannitol—Tachycardia—Prednisone—prostate cancer	0.000101	0.000323	CcSEcCtD
Mannitol—Decreased appetite—Capecitabine—prostate cancer	0.000101	0.000323	CcSEcCtD
Mannitol—Skin disorder—Prednisone—prostate cancer	0.0001	0.000322	CcSEcCtD
Mannitol—Gastrointestinal disorder—Capecitabine—prostate cancer	0.0001	0.000321	CcSEcCtD
Mannitol—Fatigue—Capecitabine—prostate cancer	0.0001	0.000321	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—prostate cancer	9.96e-05	0.00032	CcSEcCtD
Mannitol—Pain—Capecitabine—prostate cancer	9.92e-05	0.000318	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—prostate cancer	9.9e-05	0.000317	CcSEcCtD
Mannitol—Feeling abnormal—Docetaxel—prostate cancer	9.87e-05	0.000317	CcSEcCtD
Mannitol—Diarrhoea—Etoposide—prostate cancer	9.86e-05	0.000316	CcSEcCtD
Mannitol—Flatulence—Epirubicin—prostate cancer	9.75e-05	0.000313	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	9.68e-05	0.0145	CbGpPWpGaD
Mannitol—Nervousness—Epirubicin—prostate cancer	9.61e-05	0.000308	CcSEcCtD
Mannitol—Back pain—Epirubicin—prostate cancer	9.58e-05	0.000307	CcSEcCtD
Mannitol—Feeling abnormal—Capecitabine—prostate cancer	9.56e-05	0.000306	CcSEcCtD
Mannitol—Dizziness—Etoposide—prostate cancer	9.53e-05	0.000306	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—prostate cancer	9.48e-05	0.000304	CcSEcCtD
Mannitol—Body temperature increased—Docetaxel—prostate cancer	9.47e-05	0.000304	CcSEcCtD
Mannitol—Chills—Doxorubicin—prostate cancer	9.44e-05	0.000303	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Prednisone—prostate cancer	9.41e-05	0.000302	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	9.34e-05	0.014	CbGpPWpGaD
Mannitol—Vision blurred—Epirubicin—prostate cancer	9.33e-05	0.000299	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—WRN—prostate cancer	9.27e-05	0.0139	CbGpPWpGaD
Mannitol—Mental disorder—Doxorubicin—prostate cancer	9.22e-05	0.000296	CcSEcCtD
Mannitol—Urticaria—Capecitabine—prostate cancer	9.21e-05	0.000295	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—prostate cancer	9.19e-05	0.000295	CcSEcCtD
Mannitol—Body temperature increased—Capecitabine—prostate cancer	9.17e-05	0.000294	CcSEcCtD
Mannitol—Vomiting—Etoposide—prostate cancer	9.16e-05	0.000294	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—prostate cancer	9.16e-05	0.000294	CcSEcCtD
Mannitol—Rash—Etoposide—prostate cancer	9.09e-05	0.000291	CcSEcCtD
Mannitol—Dermatitis—Etoposide—prostate cancer	9.08e-05	0.000291	CcSEcCtD
Mannitol—Headache—Etoposide—prostate cancer	9.03e-05	0.00029	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—prostate cancer	9.03e-05	0.000289	CcSEcCtD
Mannitol—Decreased appetite—Prednisone—prostate cancer	8.98e-05	0.000288	CcSEcCtD
Mannitol—Malaise—Epirubicin—prostate cancer	8.93e-05	0.000286	CcSEcCtD
Mannitol—Fatigue—Prednisone—prostate cancer	8.91e-05	0.000286	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—prostate cancer	8.9e-05	0.000285	CcSEcCtD
Mannitol—Vertigo—Epirubicin—prostate cancer	8.89e-05	0.000285	CcSEcCtD
Mannitol—Back pain—Doxorubicin—prostate cancer	8.86e-05	0.000284	CcSEcCtD
Mannitol—Hypersensitivity—Docetaxel—prostate cancer	8.83e-05	0.000283	CcSEcCtD
Mannitol—Cough—Epirubicin—prostate cancer	8.64e-05	0.000277	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—prostate cancer	8.63e-05	0.000277	CcSEcCtD
Mannitol—Asthenia—Docetaxel—prostate cancer	8.59e-05	0.000276	CcSEcCtD
Mannitol—Convulsion—Epirubicin—prostate cancer	8.58e-05	0.000275	CcSEcCtD
Mannitol—Nausea—Etoposide—prostate cancer	8.56e-05	0.000275	CcSEcCtD
Mannitol—Hypertension—Epirubicin—prostate cancer	8.55e-05	0.000274	CcSEcCtD
Mannitol—Hypersensitivity—Capecitabine—prostate cancer	8.54e-05	0.000274	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	8.52e-05	0.0128	CbGpPWpGaD
Mannitol—Feeling abnormal—Prednisone—prostate cancer	8.51e-05	0.000273	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—prostate cancer	8.5e-05	0.000273	CcSEcCtD
Mannitol—Pruritus—Docetaxel—prostate cancer	8.47e-05	0.000272	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—prostate cancer	8.43e-05	0.00027	CcSEcCtD
Mannitol—Chest pain—Epirubicin—prostate cancer	8.43e-05	0.00027	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.37e-05	0.000268	CcSEcCtD
Mannitol—Discomfort—Epirubicin—prostate cancer	8.33e-05	0.000267	CcSEcCtD
Mannitol—Asthenia—Capecitabine—prostate cancer	8.32e-05	0.000267	CcSEcCtD
Mannitol—Malaise—Doxorubicin—prostate cancer	8.26e-05	0.000265	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—prostate cancer	8.23e-05	0.000264	CcSEcCtD
Mannitol—Urticaria—Prednisone—prostate cancer	8.21e-05	0.000263	CcSEcCtD
Mannitol—Pruritus—Capecitabine—prostate cancer	8.2e-05	0.000263	CcSEcCtD
Mannitol—Diarrhoea—Docetaxel—prostate cancer	8.2e-05	0.000263	CcSEcCtD
Mannitol—Body temperature increased—Prednisone—prostate cancer	8.17e-05	0.000262	CcSEcCtD
Mannitol—Oedema—Epirubicin—prostate cancer	8.08e-05	0.000259	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NDRG1—prostate cancer	8.03e-05	0.0121	CbGpPWpGaD
Mannitol—Infection—Epirubicin—prostate cancer	8.03e-05	0.000257	CcSEcCtD
Mannitol—Cough—Doxorubicin—prostate cancer	7.99e-05	0.000256	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—prostate cancer	7.94e-05	0.000255	CcSEcCtD
Mannitol—Diarrhoea—Capecitabine—prostate cancer	7.93e-05	0.000254	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—prostate cancer	7.92e-05	0.000254	CcSEcCtD
Mannitol—Dizziness—Docetaxel—prostate cancer	7.92e-05	0.000254	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—prostate cancer	7.91e-05	0.000254	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—prostate cancer	7.89e-05	0.000253	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—prostate cancer	7.85e-05	0.000252	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—prostate cancer	7.8e-05	0.00025	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—prostate cancer	7.8e-05	0.00025	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.74e-05	0.000248	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—prostate cancer	7.7e-05	0.000247	CcSEcCtD
Mannitol—Dizziness—Capecitabine—prostate cancer	7.67e-05	0.000246	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—prostate cancer	7.66e-05	0.0115	CbGpPWpGaD
Mannitol—Vomiting—Docetaxel—prostate cancer	7.62e-05	0.000244	CcSEcCtD
Mannitol—Hypersensitivity—Prednisone—prostate cancer	7.61e-05	0.000244	CcSEcCtD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	7.57e-05	0.0114	CbGpPWpGaD
Mannitol—Rash—Docetaxel—prostate cancer	7.55e-05	0.000242	CcSEcCtD
Mannitol—Hypotension—Epirubicin—prostate cancer	7.55e-05	0.000242	CcSEcCtD
Mannitol—Dermatitis—Docetaxel—prostate cancer	7.55e-05	0.000242	CcSEcCtD
Mannitol—Headache—Docetaxel—prostate cancer	7.5e-05	0.000241	CcSEcCtD
Mannitol—Oedema—Doxorubicin—prostate cancer	7.48e-05	0.00024	CcSEcCtD
Mannitol—Infection—Doxorubicin—prostate cancer	7.43e-05	0.000238	CcSEcCtD
Mannitol—Asthenia—Prednisone—prostate cancer	7.41e-05	0.000238	CcSEcCtD
Mannitol—Vomiting—Capecitabine—prostate cancer	7.37e-05	0.000236	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.36e-05	0.000236	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—prostate cancer	7.33e-05	0.000235	CcSEcCtD
Mannitol—Rash—Capecitabine—prostate cancer	7.31e-05	0.000235	CcSEcCtD
Mannitol—Pruritus—Prednisone—prostate cancer	7.31e-05	0.000234	CcSEcCtD
Mannitol—Dermatitis—Capecitabine—prostate cancer	7.31e-05	0.000234	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—prostate cancer	7.3e-05	0.000234	CcSEcCtD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—prostate cancer	7.3e-05	0.011	CbGpPWpGaD
Mannitol—Headache—Capecitabine—prostate cancer	7.27e-05	0.000233	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—prostate cancer	7.26e-05	0.000233	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—prostate cancer	7.2e-05	0.000231	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	7.18e-05	0.0108	CbGpPWpGaD
Mannitol—Nausea—Docetaxel—prostate cancer	7.11e-05	0.000228	CcSEcCtD
Mannitol—Diarrhoea—Prednisone—prostate cancer	7.07e-05	0.000227	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—prostate cancer	7.02e-05	0.000225	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—prostate cancer	6.99e-05	0.000224	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—prostate cancer	6.98e-05	0.000224	CcSEcCtD
Mannitol—Fatigue—Epirubicin—prostate cancer	6.97e-05	0.000223	CcSEcCtD
Mannitol—Pain—Epirubicin—prostate cancer	6.91e-05	0.000222	CcSEcCtD
Mannitol—Nausea—Capecitabine—prostate cancer	6.89e-05	0.000221	CcSEcCtD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	6.83e-05	0.0103	CbGpPWpGaD
Mannitol—Dizziness—Prednisone—prostate cancer	6.83e-05	0.000219	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.81e-05	0.000218	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—prostate cancer	6.66e-05	0.000214	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—prostate cancer	6.66e-05	0.000214	CcSEcCtD
Mannitol—Vomiting—Prednisone—prostate cancer	6.57e-05	0.000211	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—VIM—prostate cancer	6.54e-05	0.00982	CbGpPWpGaD
Mannitol—Rash—Prednisone—prostate cancer	6.51e-05	0.000209	CcSEcCtD
Mannitol—Dermatitis—Prednisone—prostate cancer	6.51e-05	0.000209	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—prostate cancer	6.5e-05	0.000208	CcSEcCtD
Mannitol—Headache—Prednisone—prostate cancer	6.47e-05	0.000208	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.45e-05	0.000207	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—prostate cancer	6.45e-05	0.000207	CcSEcCtD
Mannitol—Urticaria—Epirubicin—prostate cancer	6.42e-05	0.000206	CcSEcCtD
Mannitol—Pain—Doxorubicin—prostate cancer	6.39e-05	0.000205	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—prostate cancer	6.39e-05	0.000205	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—prostate cancer	6.16e-05	0.000198	CcSEcCtD
Mannitol—Nausea—Prednisone—prostate cancer	6.14e-05	0.000197	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—prostate cancer	5.95e-05	0.000191	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—prostate cancer	5.94e-05	0.00019	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—prostate cancer	5.91e-05	0.00019	CcSEcCtD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	5.89e-05	0.00885	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—prostate cancer	5.88e-05	0.00883	CbGpPWpGaD
Mannitol—Asthenia—Epirubicin—prostate cancer	5.8e-05	0.000186	CcSEcCtD
Mannitol—Pruritus—Epirubicin—prostate cancer	5.72e-05	0.000183	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—prostate cancer	5.53e-05	0.000177	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—prostate cancer	5.51e-05	0.000177	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—prostate cancer	5.36e-05	0.000172	CcSEcCtD
Mannitol—Dizziness—Epirubicin—prostate cancer	5.34e-05	0.000171	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—prostate cancer	5.29e-05	0.00017	CcSEcCtD
Mannitol—Vomiting—Epirubicin—prostate cancer	5.14e-05	0.000165	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—prostate cancer	5.11e-05	0.000164	CcSEcCtD
Mannitol—Rash—Epirubicin—prostate cancer	5.09e-05	0.000163	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—prostate cancer	5.09e-05	0.000163	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	5.08e-05	0.00763	CbGpPWpGaD
Mannitol—Headache—Epirubicin—prostate cancer	5.06e-05	0.000162	CcSEcCtD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	4.97e-05	0.00747	CbGpPWpGaD
Mannitol—Dizziness—Doxorubicin—prostate cancer	4.94e-05	0.000159	CcSEcCtD
Mannitol—Nausea—Epirubicin—prostate cancer	4.8e-05	0.000154	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NCOA2—prostate cancer	4.78e-05	0.00717	CbGpPWpGaD
Mannitol—Vomiting—Doxorubicin—prostate cancer	4.75e-05	0.000152	CcSEcCtD
Mannitol—Rash—Doxorubicin—prostate cancer	4.71e-05	0.000151	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—prostate cancer	4.71e-05	0.000151	CcSEcCtD
Mannitol—Headache—Doxorubicin—prostate cancer	4.68e-05	0.00015	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CXCL12—prostate cancer	4.45e-05	0.00669	CbGpPWpGaD
Mannitol—Nausea—Doxorubicin—prostate cancer	4.44e-05	0.000142	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—prostate cancer	4.16e-05	0.00625	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—PRKCZ—prostate cancer	4.14e-05	0.00621	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	4.04e-05	0.00606	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	4.02e-05	0.00605	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CXCL12—prostate cancer	3.85e-05	0.00579	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CASP9—prostate cancer	3.63e-05	0.00545	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	3.62e-05	0.00544	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—TERT—prostate cancer	2.97e-05	0.00447	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL10—prostate cancer	2.92e-05	0.00439	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	2.86e-05	0.00429	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	2.84e-05	0.00427	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—LEP—prostate cancer	2.78e-05	0.00417	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	2.74e-05	0.00412	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—FASLG—prostate cancer	2.72e-05	0.00408	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	2.6e-05	0.00391	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	2.55e-05	0.00383	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	2.33e-05	0.0035	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	2.32e-05	0.00349	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	2.32e-05	0.00348	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	2.29e-05	0.00343	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	2.26e-05	0.0034	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	2.21e-05	0.00332	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	2.18e-05	0.00327	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	2.12e-05	0.00319	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	2.11e-05	0.00317	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	2.08e-05	0.00312	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	2.02e-05	0.00303	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	2.01e-05	0.00303	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	1.98e-05	0.00297	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	1.87e-05	0.0028	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	1.81e-05	0.00272	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	1.79e-05	0.00269	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	1.75e-05	0.00263	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	1.75e-05	0.00262	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	1.7e-05	0.00255	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	1.65e-05	0.00248	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	1.64e-05	0.00247	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	1.64e-05	0.00246	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	1.6e-05	0.00241	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	1.6e-05	0.00241	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CXCL8—prostate cancer	1.6e-05	0.0024	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	1.58e-05	0.00238	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	1.53e-05	0.0023	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CASP3—prostate cancer	1.53e-05	0.0023	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL2—prostate cancer	1.53e-05	0.00229	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	1.5e-05	0.00226	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	1.5e-05	0.00225	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HAO1—prostate cancer	1.47e-05	0.0022	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	1.46e-05	0.00219	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	1.4e-05	0.00211	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	1.34e-05	0.00201	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.3e-05	0.00195	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—VEGFA—prostate cancer	1.3e-05	0.00195	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GRHL1—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ADI1—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CSAD—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TST—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CBR1—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PSAT1—prostate cancer	1.2e-05	0.0018	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—TGFB1—prostate cancer	1.19e-05	0.00179	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	1.14e-05	0.00172	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	1.13e-05	0.0017	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UGT2B17—prostate cancer	1.11e-05	0.00167	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UGT2B15—prostate cancer	1.11e-05	0.00167	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GRHPR—prostate cancer	1.11e-05	0.00167	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CKMT2—prostate cancer	1.11e-05	0.00167	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.11e-05	0.00166	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.07e-05	0.00161	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.06e-05	0.00159	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.06e-05	0.00159	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PGAM2—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MBTPS1—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NAGLU—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SULT2B1—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—RFK—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTM3—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AOX1—prostate cancer	1.04e-05	0.00157	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.01e-05	0.00151	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	9.92e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AMACR—prostate cancer	9.91e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP3A43—prostate cancer	9.91e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NAT1—prostate cancer	9.91e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—DEGS1—prostate cancer	9.91e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SRD5A2—prostate cancer	9.91e-06	0.00149	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	9.8e-06	0.00147	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	9.56e-06	0.00144	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	9.47e-06	0.00142	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSD17B1—prostate cancer	9.45e-06	0.00142	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	9.01e-06	0.00135	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	8.59e-06	0.00129	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	8.55e-06	0.00129	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	8.43e-06	0.00127	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—B4GALT4—prostate cancer	8.42e-06	0.00127	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HPGD—prostate cancer	8.42e-06	0.00127	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	8.31e-06	0.00125	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	8.13e-06	0.00122	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	8.11e-06	0.00122	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TNFRSF21—prostate cancer	7.92e-06	0.00119	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	7.73e-06	0.00116	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP7B1—prostate cancer	7.7e-06	0.00116	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTAP—prostate cancer	7.7e-06	0.00116	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	7.7e-06	0.00116	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	7.54e-06	0.00113	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SULT1E1—prostate cancer	7.51e-06	0.00113	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SRD5A1—prostate cancer	7.51e-06	0.00113	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	7.34e-06	0.0011	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	7.27e-06	0.00109	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ACSL4—prostate cancer	7.16e-06	0.00108	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSD17B3—prostate cancer	7.16e-06	0.00108	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	7.1e-06	0.00107	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	7.09e-06	0.00106	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PHGDH—prostate cancer	6.87e-06	0.00103	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ARG2—prostate cancer	6.87e-06	0.00103	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UMPS—prostate cancer	6.87e-06	0.00103	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.83e-06	0.00103	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	6.76e-06	0.00102	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—LDHB—prostate cancer	6.73e-06	0.00101	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP3A5—prostate cancer	6.61e-06	0.000993	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	6.57e-06	0.000987	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	6.5e-06	0.000976	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	6.4e-06	0.000962	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PDHA1—prostate cancer	6.38e-06	0.000959	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UCP3—prostate cancer	6.38e-06	0.000959	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TCN2—prostate cancer	6.38e-06	0.000959	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA3—prostate cancer	6.38e-06	0.000959	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSD3B1—prostate cancer	6.09e-06	0.000915	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC22A3—prostate cancer	6.09e-06	0.000915	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	5.89e-06	0.000885	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.88e-06	0.000883	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TBXAS1—prostate cancer	5.84e-06	0.000877	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA4—prostate cancer	5.84e-06	0.000877	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.76e-06	0.000865	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA2—prostate cancer	5.69e-06	0.000855	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SULT1A1—prostate cancer	5.62e-06	0.000844	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ABCG5—prostate cancer	5.62e-06	0.000844	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTA1—prostate cancer	5.49e-06	0.000825	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	5.44e-06	0.000817	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTO1—prostate cancer	5.43e-06	0.000815	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSD3B2—prostate cancer	5.43e-06	0.000815	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NAT2—prostate cancer	5.43e-06	0.000815	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—LRP2—prostate cancer	5.2e-06	0.000782	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP2C18—prostate cancer	5.2e-06	0.000782	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PLCB2—prostate cancer	5.2e-06	0.000782	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—P4HB—prostate cancer	5.1e-06	0.000767	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5e-06	0.000751	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC22A1—prostate cancer	4.96e-06	0.000746	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.96e-06	0.000745	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SULT2A1—prostate cancer	4.84e-06	0.000727	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.84e-06	0.000727	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MED12—prostate cancer	4.76e-06	0.000715	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GNG5—prostate cancer	4.72e-06	0.000709	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA3—prostate cancer	4.55e-06	0.000683	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HPGDS—prostate cancer	4.34e-06	0.000652	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP2C19—prostate cancer	4.31e-06	0.000648	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ACHE—prostate cancer	4.21e-06	0.000632	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTT1—prostate cancer	4.21e-06	0.000632	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP2A6—prostate cancer	4.16e-06	0.000625	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.08e-06	0.000614	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AKR1C3—prostate cancer	4.05e-06	0.000608	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PRKACB—prostate cancer	4.03e-06	0.000605	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP17A1—prostate cancer	3.98e-06	0.000598	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.94e-06	0.000592	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA2—prostate cancer	3.8e-06	0.00057	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC5A5—prostate cancer	3.62e-06	0.000544	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP2E1—prostate cancer	3.54e-06	0.000531	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NQO1—prostate cancer	3.5e-06	0.000525	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TH—prostate cancer	3.45e-06	0.000518	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP3A4—prostate cancer	3.41e-06	0.000512	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP1B1—prostate cancer	3.35e-06	0.000504	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GGT1—prostate cancer	3.25e-06	0.000488	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA1—prostate cancer	3.2e-06	0.000481	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP19A1—prostate cancer	3.15e-06	0.000474	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—RXRA—prostate cancer	3.04e-06	0.000457	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—COMT—prostate cancer	2.93e-06	0.00044	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTP1—prostate cancer	2.92e-06	0.000438	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ITPR1—prostate cancer	2.87e-06	0.000431	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TYMS—prostate cancer	2.71e-06	0.000407	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTM1—prostate cancer	2.68e-06	0.000403	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—LPL—prostate cancer	2.63e-06	0.000395	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYP1A1—prostate cancer	2.54e-06	0.000382	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ERCC2—prostate cancer	2.52e-06	0.000379	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTHFR—prostate cancer	2.37e-06	0.000356	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PPARA—prostate cancer	2.32e-06	0.000349	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CAV1—prostate cancer	2.19e-06	0.000328	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CG—prostate cancer	1.99e-06	0.000299	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—INS—prostate cancer	1.88e-06	0.000283	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CREBBP—prostate cancer	1.85e-06	0.000277	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CD—prostate cancer	1.75e-06	0.000263	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NOS3—prostate cancer	1.65e-06	0.000248	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CB—prostate cancer	1.53e-06	0.000229	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTGS2—prostate cancer	1.51e-06	0.000227	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTEN—prostate cancer	1.32e-06	0.000198	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—EP300—prostate cancer	1.26e-06	0.000189	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CA—prostate cancer	9.3e-07	0.00014	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AKT1—prostate cancer	7.6e-07	0.000114	CbGpPWpGaD
